50881-0025 Jakafi - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50881-0025

Brand Name:

Jakafi

Generic Name:

Ruxolitinib

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Ruxolitinib

Strength: 25.0

Unit: mg/1

Packages:

Code: 50881-0025-60

Description: 60 TABLET in 1 BOTTLE, PLASTIC (50881-025-60)

Effective Date: Nov. 16, 2011

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

JAK 1/2

Orphan Drug Designation:

Yes

Status:

In Use